InvestorsHub Logo
Followers 466
Posts 26938
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 59

Wednesday, 11/20/2013 9:07:14 AM

Wednesday, November 20, 2013 9:07:14 AM

Post# of 116
7:08AM Myriad Genetics announces a research collaboration with BioMarin (BMRN) that will use Myriad's novel HRD (MYGN) 27.59 : Co announces a research collaboration with BioMarin (BRMN) that will use Myriad's novel HRD (Homologous Recombination Deficiency) test to identify tumor types that may be sensitive to BioMarin's investigational product candidate, BMN-673. Specific terms of the deal were not disclosed.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYGN News